In summary, we produced some evidence that supports the idea that decreases in PE, as a consequence of SELENOI dysregulation, may cause changes to neuronal integrity and function, leading to neuropathology in ALS. The gene discussed is SELENOI; the disease is amyotrophic lateral sclerosis.